6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension

• Status: Not yet recruiting
• Trial end date: 2023-04-30
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: General Hospital of Ningxia Medical University
• Treatments: Hydroxyethyl Starch Derivatives

Criteria

Inclusion Criteria:

• 18-40 years

• Primipara or multipara

• Singleton pregnancy ≥ 37 weeks

• American Society of Anesthesiologists physical status classification I to II

• Scheduled for elective cesarean section under spinal anesthesia

Exclusion Criteria:

• Body height < 150 cm

• Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2

• Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg

• Hemoglobin < 7g/dl

• Coagulation or renal function disorders

• Known allergy to hydroxyethyl starch

• Fetal distress, or known fetal developmental anomaly